[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335786-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335786-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","stk33-as-the-functional-substrate-of-mir-454-3p-for-suppression-and-apoptosis-in-neuroblastoma-molecular-and-cellular-research-article","STK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma - Molecular and Cellular Research Article","","miR-454-3p is reported as a tumor-suppressive microRNA across multiple cancers. This study identifies the kinase STK33 mRNA as a miR-454-3p substrate in neuroblastoma and links STK33 to high-risk survival in patients. miR-454-3p mimic reduces neuroblastoma cell growth and viability, with mimic/antagonist showing the strongest effects on STK33 RNA and protein changes. STK33 is validated by luciferase reporter assays and miR-454-3p–resistant STK33 constructs. miR-454-3p overexpression or STK33 knockdown promotes autophagy while increasing apoptotic markers. Targeting STK33-dependent neuroblastoma using a suppressive miRNA is proposed as an alternative therapeutic strategy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/stk33-as-the-functional-substrate-of-mir-454-3p-for-suppression-and-apoptosis-in-neuroblastoma-molecular-and-cellular-research-article/335786/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/stk33-as-the-functional-substrate-of-mir-454-3p-for-suppression-and-apoptosis-in-neuroblastoma-molecular-and-cellular-research-article/335786.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does miR-454-3p play in neuroblastoma according to the study?","Question",{"text":63,"@type":64},"miR-454-3p acts as a tumor-suppressive microRNA in neuroblastoma cells by reducing growth and viability and promoting autophagy alongside increased apoptotic markers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study identify STK33 as a functional substrate of miR-454-3p?",{"text":68,"@type":64},"STK33 was validated using miRNA database/literature screening, luciferase reporter assays, and recombinant STK33 versions resistant to miR-454-3p, which reduced the miRNA’s suppressive effect.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular processes were affected by altering miR-454-3p or STK33 levels?",{"text":72,"@type":64},"Overexpression of miR-454-3p or knockdown of STK33 promoted autophagy and increased apoptotic markers in tested neuroblastoma cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335786,1790893276,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Molecules and Cells Research Article  \nSTK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma  \nDongkwan Yoo, Sichen Wu, Seunghyuk Choi, Sung-Oh Huh⁎, and Ali Sadra⁎  \nDepartment of Pharmacology, College of Medicine, Institute of Natural Medicine, Hallym University, Chuncheon, Gangwon State, Republic of Korea  \n⁎Correspondence: [s0huh@hallym.ac.kr](s0huh@hallym.ac.kr) (S.-O. Huh), [alisadra@hallym.ac.kr](alisadra@hallym.ac.kr) (A. Sadra) .  \n[https://doi.org/10.1016/j.mocell.2024.100145](https://doi.org/10.1016/j.mocell.2024.100145)  \nABSTRACT  \nmiR-454-3p has been reported to be a tumor-suppressive microRNA (miRNA) in multiple cancer types. We identified the kinase STK33 mRNA, which is a high-risk factor for survival in neuroblastoma (NB) patients, as being a substrate of miR- 454-3p in NB. Even though STK33 is an attractive target for several cancers, the development of inhibitors of STK33 has been challenging. For the various cell lines tested, we demonstrated reduced growth and viability with the miR-454-3p mimic. From among the candidate NB-associated miRNAs, miR-454-3p mimic and its antagonist had the most profound effect on STK33 mRNA and protein-level changes. Under various conditions of growth and external stress for the cells, the RNA levels for miR-454-3p and STK33 also negatively correlated. Luciferase reporter assays demonstrated STK33 as a substrate for miR-454-3p, and recombinant versions of STK33 resistant to miR-454-3p significantly blunted the suppressive effect of the miR-454-3p and established STK33 as the major functional substrate of miR-454-3p. Overexpression of miR-454-3p or knockdown of STK33 mRNA promoted autophagy and at the same time, increased the apoptotic markers in the tested NB cells, indicating a mechanism for the suppressive effect of the agents. Given the difficult-to-drug targets such as STK33 and the recent successes in RNA delivery methods for cancer treatment, it is thought that targeting cancer cells with a suppressive miRNA such as miR-454-3p for STK33-dependent cancer types may be an alternative means of NB therapy.  \n© 2024 Published by Elsevier Inc. on behalf of Korean Society for Molecular and Cellular Biology. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4 .0/) .  \nKeywords: MiR-454-3p, Neuroblastoma, RNA targeting, Serine/threonine kinase 33, Suppressive microRNA  \nINTRODUCTION  \nNeuroblastoma (NB) is a pediatric cancer that originates from the sympathetic arm of the nervous system. The cancer cells are neuroblasts from lymph nodes, bone marrow, and other organs, but specifically form outside of the cranium. NB also represents 15% of death from pediatric cancers (Lundberg et al. , 2022; Monclair et al. , 2009) . The therapies for NB involve surgery, radiation treatment, and regimens of chemotherapy, whose success depends on the risk categories, with the stage 4 and 4s, representing metastatic cancer and stage 4 having the highest risk and worst outcome (Zhong et al. , 2018) . Most recently, there has been an interest in obtaining messenger RNA (mRNA) signatures for NB cases for better addressing their prognosis and treatment options (Zhong et al. , 2018) . The focus has also been on characterizing the function of various RNA-interacting proteins and regulatory RNA in NB (Bishayeeet al. , 2022; Schulte et al. , 2010) .  \nMicroRNAs (miRNAs) are a group of RNA species that do not code for protein and are involved in numerous essential  \nfunctions for normal physiology. They have also been implicated in various states of pathology, such as tumor development (Bartel, 2018) . miRNAs function by regulating the half-life of their target mRNA; this is mainly by antisense base-pairing to specific nucleotides in the 3′ untranslated region (3′ UTR) of their target, driving subsequent degradation and/or translation block of the bound mRNA (Behm-Ansmant et al. ,","cbCaivGe02XOWlL7","https://ap.wps.com/l/cbCaivGe02XOWlL7","pdf",6918359,15,"English","# Abstract\n# Introduction\n## Neuroblastoma and current therapies\n## MicroRNAs and miRNA-mediated regulation","[{\"question\":\"What role does miR-454-3p play in neuroblastoma according to the study?\",\"answer\":\"miR-454-3p acts as a tumor-suppressive microRNA in neuroblastoma cells by reducing growth and viability and promoting autophagy alongside increased apoptotic markers.\"},{\"question\":\"How did the study identify STK33 as a functional substrate of miR-454-3p?\",\"answer\":\"STK33 was validated using miRNA database/literature screening, luciferase reporter assays, and recombinant STK33 versions resistant to miR-454-3p, which reduced the miRNA’s suppressive effect.\"},{\"question\":\"What cellular processes were affected by altering miR-454-3p or STK33 levels?\",\"answer\":\"Overexpression of miR-454-3p or knockdown of STK33 promoted autophagy and increased apoptotic markers in tested neuroblastoma cells.\"}]","STK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma - Molecular and Cellular Research Article | PDF",1790012340,38]